Who Will Benefit? Using Radiomics to Predict Response to Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastases.
- Resource Type
- Editorial
- Source
- Annals of Surgical Oncology: An Oncology Journal for Surgeons; Jun2021, Vol. 28 Issue 6, p2931-2933, 3p
- Subject
- Language
- ISSN
- 10689265